You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2025

Details for Patent: 4,454,152


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,454,152
Title: Methoxsalen dosage forms
Abstract:This invention relates to oral dosage forms wherein the active ingredient, methoxsalen, is dispersed in a water-soluble composition containing a polyethylene glycol or mixtures of polyethylene glycols. Dissolution of methoxsalen in gastrointestinal fluids as well as drug absorption are more rapid and higher blood level patterns are achieved with these dosage forms as compared to conventional encapsulated dosage forms.
Inventor(s): Barry; Richard H. (Bloomfield, NJ), Lazarus; Jack H. (Jersey City, NJ)
Assignee: Hoffmann-La Roche Inc. (Nutley, NJ)
Application Number:06/332,982
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,454,152

Introduction

United States Patent 4,454,152, hereafter referred to as the '152 patent, is a significant document in the patent landscape. To analyze its scope and claims, we need to delve into the specifics of the patent, its historical context, and the broader implications within the patent system.

Patent Overview

The '152 patent, like any other patent, consists of several key components:

  • Title and Abstract: These provide a brief overview of the invention.
  • Background of the Invention: This section explains the context and prior art related to the invention.
  • Summary of the Invention: A concise description of the invention and its main features.
  • Detailed Description of the Invention: A thorough explanation of how the invention works, often including drawings and diagrams.
  • Claims: These are the legally binding definitions of the invention and what is protected by the patent.

Claims Analysis

The claims section is the most critical part of a patent as it defines the scope of protection. Here are some key points to consider:

Independent and Dependent Claims

  • Independent claims stand alone and define the invention without reference to other claims.
  • Dependent claims refer back to an independent claim and further limit the scope of the invention[4].

Claim Construction

The interpretation of claims is crucial for determining the patent's scope. This involves understanding the language used, the context provided by the specification, and any relevant prior art[4].

Patent Scope

The scope of a patent is determined by its claims and is influenced by several factors:

Patent Term

The '152 patent, granted before the current patent term adjustments, would have had a term of 17 years from the date of grant. Modern patents, however, have a term of 20 years from the earliest filing date, subject to adjustments for delays during prosecution[1].

Patent Term Adjustments (PTA)

While the '152 patent would not have been subject to PTA, understanding PTA is crucial for modern patents. PTA can extend the patent term due to delays caused by the USPTO during the prosecution process[1].

Historical Context

The '152 patent was granted in an era different from today's, with different patent laws and regulations. For example, the America Invents Act (AIA) of 2011 introduced significant changes to the U.S. patent system, including the switch from a first-to-invent to a first-to-file system.

Prior Art and Obviousness

Prior art and obviousness are critical in determining the validity of a patent. The '152 patent would have been evaluated against the prior art existing at the time of its filing. Modern patents are subject to more stringent obviousness standards, as outlined in cases such as KSR International Co. v. Teleflex Inc.[4].

Search and Examination Process

To understand the '152 patent, one must consider the search and examination process it underwent. Today, the USPTO uses advanced tools like the Patent Public Search and Global Dossier to ensure thorough prior art searches and to maintain consistency across different jurisdictions[4].

Patent Landscape

The patent landscape around the '152 patent includes other related patents and applications. Here are some points to consider:

Continuations and Continuations-in-Part

Like the patents discussed in the In re Cellect case, the '152 patent might be part of a family of patents, including continuations and continuations-in-part. These relationships can affect the patent's scope and term[1].

Patent Families and Global Dossier

Using tools like the Global Dossier, one can trace the patent family of the '152 patent, including related applications filed in other jurisdictions. This helps in understanding the broader patent landscape and potential overlaps or conflicts[4].

Practical Implications

Understanding the scope and claims of the '152 patent has practical implications for several stakeholders:

Inventors and Patent Holders

For inventors and patent holders, knowing the exact scope of protection is crucial for enforcing their rights and avoiding infringement.

Competitors and Licensees

Competitors need to understand the patent's scope to avoid infringement, while licensees must comprehend what they are licensing and the terms of the agreement.

Legal Considerations

The legal framework surrounding the '152 patent includes various statutes and case laws:

Obviousness-Type Double Patenting (ODP)

ODP is a concept that prevents an inventor from securing multiple patents for the same invention. This is particularly relevant in cases involving continuations and continuations-in-part, as seen in In re Cellect[1].

Terminal Disclaimers

Terminal disclaimers can be used to overcome ODP rejections by disclaiming the term of a later patent that would otherwise extend beyond the term of an earlier patent[1].

Conclusion

Understanding the scope and claims of United States Patent 4,454,152 involves a detailed analysis of its components, historical context, and the broader patent landscape. Here are the key takeaways:

  • Claims Analysis: The claims define the scope of protection and are critical for determining the patent's validity and enforceability.
  • Patent Term and Adjustments: The patent term and any adjustments due to prosecution delays are important for understanding the patent's lifespan.
  • Prior Art and Obviousness: The patent must be evaluated against prior art and obviousness standards to ensure its validity.
  • Patent Landscape: Understanding the patent family and related applications is essential for a comprehensive analysis.
  • Legal Considerations: ODP, terminal disclaimers, and other legal concepts are vital for navigating the patent system.

Key Takeaways

  • Claims Define Scope: The claims section is the most critical part of a patent.
  • Historical Context: The patent was granted under different laws and regulations.
  • Prior Art and Obviousness: These are crucial for determining the patent's validity.
  • Patent Term and Adjustments: Understanding the patent term and any adjustments is important.
  • Patent Landscape: Analyzing related patents and applications is essential.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The claims section defines the scope of protection and what is legally protected by the patent.

Q: How does the America Invents Act (AIA) affect patent terms? A: The AIA introduced a first-to-file system and changed the patent term to 20 years from the earliest filing date.

Q: What is Obviousness-Type Double Patenting (ODP)? A: ODP prevents an inventor from securing multiple patents for the same invention, ensuring that a second patent does not extend beyond the term of an earlier patent.

Q: What tools does the USPTO use for prior art searches? A: The USPTO uses tools like the Patent Public Search and Global Dossier to ensure thorough prior art searches.

Q: Why is understanding the patent family important? A: Understanding the patent family helps in identifying related applications and potential overlaps or conflicts, which is crucial for navigating the patent landscape.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,454,152

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 4,454,152

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 545363 ⤷  Try for Free
Australia 7006981 ⤷  Try for Free
Canada 1173751 ⤷  Try for Free
Denmark 193381 ⤷  Try for Free
European Patent Office 0039874 ⤷  Try for Free
Ireland 51243 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.